Search Within

Steven M Horwitz

Formats
  1. Meeting Abstract (374)
  2. Journal Article (248)
  3. Review (13)
  4. Guidelines (11)
  5. Research Letter (9)
  6. Book Section (6)
  7. Correspondence (5)
  8. Editorial (4)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (671)
  2. Department of Medicine (671)
  3. Hematologic Malignancies, Division of (671)
  4. Lymphoma (671)
  5. Population Sciences Research Program (671)
  6. Survivorship Research (173)

More Groups

People
  1. Alison Moskowitz (235)
  2. Andrew Zelenetz (169)
  3. Paul Hamlin (140)
  4. Ariela Noy (139)
  5. David Straus (122)
  6. Maria Palomba (112)

More People

Years
  1. 2025 (18)
  2. 2024 (51)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (53)
  6. 2020 (52)

More Years

Publications
  1. Blood (255)
  2. Journal of Clinical Oncology (64)
  3. Hematological Oncology (38)
  4. Blood Advances (19)
  5. Leukemia and Lymphoma (19)
  6. Annals of Oncology (18)

More Publications

Publishers
  1. American Society of Hematology (277)
  2. American Society of Clinical Oncology (65)
  3. Wiley Blackwell (55)
  4. Elsevier Inc. (34)
  5. Oxford University Press (25)
  6. Taylor & Francis Group (23)

More Publishers

Results (671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II intergroup trial of alisertib in relapsed and refractory peripheral T-cell lymphoma and transformed Mycosis fungoides: SWOG 1108
    Journal Article

    Barr, P. M.; Li, H.; Spier, C.; Mahadevan, D.; LeBlanc, M.; Ul Haq, M.; Huber, B. D.; Flowers, C. R.; Wagner-Johnston, N. D.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effect of prednisone and rituximab prephase on early toxicity in older DLBCL patients (pts) receiving RCHOP within a NHL specific comprehensive geriatric assessment (CGA) trial
    Meeting Abstract

    Owens, C. N.; Iannotta, A.; Gerecitano, J. F.; Matasar, M. J.; Noy, A.; Moskowitz, C. H.; Drullinsky, P.; Palomba, M. L.; Straus, D. J.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Activity in T-cell lymphoma
    Meeting Abstract

    Mehta-Shah, N; Lunning, M. A.; Boruchov, A. M.; Ruan, J.; Nair, S.; Lynch, P.; Byrne, R.; Moskowitz, A. J.; Matasar, M. J.; Gerecitano, J. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • CD30+ expression in peripheral T-cell lymphomas (PTCLs): A subset analysis from the international, prospective T-Cell Project
    Meeting Abstract

    Federico, M.; Bellei, M.; Luminari, S.; Horwitz, S. M.; Montoto, S.; Zucca, E.; Pileri, S. A.; Ko, Y. H.; Zinzani, P. L.; Connors, J. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Serum chemokines and cytokines in CLL patients treated with duvelisib, a PI3K-δ,γ inhibitor
    Meeting Abstract

    Douglas, M.; Allen, K.; Sweeney, J.; O'Brien, S. M.; Flinn, I.; Horwitz, S. M.; Byrd, J. C.; Patel, M. R.; Kahl, B. S.; Foss, F. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Breast implant-associated anaplastic large cell lymphoma: Proposal for optimal management
    Meeting Abstract

    Clemens, M. W.; Butler, C. E.; Hunt, K.; Fanale, M. A.; Horwitz, S. M.; Liu, H.; Mccarthy, C.; Nastoupil, L. J.; Liu, J.; Medeiros, L. J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Therapy for peripheral T-cell lymphomas: Where we are and where we hope to be
    Journal Article

    Mehta-Shah, N; Horwitz, S.
    Oncology (Norwalk) (2015)

    Fulltext@MSK | Save
  • Current and novel treatment options for peripheral T-cell lymphoma [Interview]
    Journal Article

    Horwitz, S. M.
    Clinical Advances in Hematology & Oncology (2015)

    Fulltext@MSK | Save
  • mTOR inhibition in T-cell lymphoma: A path(way) forward
    Journal Article

    Moskowitz, A. J.; Horwitz, S. M.
    Blood (2015)

    Fulltext@MSK | Save
  • Utility of 18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma
    Journal Article

    Horwitz, S.; Coiffier, B.; Foss, F.; Prince, H. M.; Sokol, L.; Greenwood, M.; Caballero, D.; Morschhauser, F.; Pinter-Brown, L.; Iyer, S. P.; more...
    Annals of Oncology (2015)

    Fulltext@MSK | Save